Table 2.
Baseline characteristics of COVID-19 ICU patients and post-surgery control patients aged 18-60years.
| COVID-19 induced sepsis <60years; n=51 |
postoperative patients <60years; n=23 | p-value | |
|---|---|---|---|
| gender male | 33 (65%) | 9 (39%) | 0.047 |
| CMV-IgG positive at day one | 44 (86%) | 14 (61%) | 0.030 |
| age in years median (IQR) | 49 (45-56) | 50 (35-57) | 0.935 |
| SOFA score at day one median (IQR) | 9 (5,5-12) | n.a. | |
| Co-Morbidities | |||
| - pulmonal (non copd) | 3 (7%) | 3 (13%) | 0.657 |
| - copd | 2 (5%) | 4 (17%) | 0.174 |
| - nicotin | 4 (10%) | 7 (30%) | 0.043 |
| - diabetes | 11 (26%) | 3 (13%) | 0.345 |
| - hypertension | 18 (43%) | 9 (39%) | 0.799 |
| - obesity | 24 (57%) | 6 (26%) | 0.021 |
| - cardiovascular | 4 (10%) | 2 (8%) | 1.000 |
| - malignant | 2 (5%) | 20 (87%) | 0.001 |
| - alcohol | 1 (2%) | 3 (13%) | 0.123 |
| - transplantation | 3 (7%) | 1 (4%) | 1.000 |
| - Kidney (non rrt) | 5 (12%) | 1 (4%) | 0.411 |
| - renal replacement therapy | 0 (0%) | 0 (0%) | n.a. |
| length of stay on ICU days median (IQR) | 21 (6-35) | n.a. | n.a. |
| length of stay in hospital median (IQR) | 23 (10,5-42,5) | 13 (6-22) | 0.025 |
| 30-day survival | 30 (59%) | 23 (100%) | 0.001 |
n.a., not applicable.